Deferred Research And Development Arrangement (Details) - USD ($) |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
Dec. 31, 2003 |
Feb. 05, 2018 |
|
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||
| Other income | $ 368,750 | |||
| Percentage of licensing revenue | 50.00% | |||
| Rexgene Biotech Co., Ltd. [Member] | ||||
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||
| Research and development arrangement, one-time fee | $ 1,500,000 | |||
| Reduction of research and development expenses | $ 6,250 | $ 18,750 | ||
| Research and development period | 20 years | |||
| Other income | $ 368,750 | |||
| Maximum [Member] | ||||
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||
| Licensing revenue agreement | $ 5,000,000 | |||
| X | ||||||||||
- Definition Licensing Revenue Agreement No definition available.
|
| X | ||||||||||
- Definition Licensing Revenue Agreement, Percent No definition available.
|
| X | ||||||||||
- Definition Research And Developement Agreement Period No definition available.
|
| X | ||||||||||
- Definition Research And Developement Agreement Period Expense Reduction Amount No definition available.
|
| X | ||||||||||
- Definition Amount of income related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|